These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11830555)

  • 1. Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models.
    Colombo B; Curnis F; Foglieni C; Monno A; Arrigoni G; Corti A
    Cancer Res; 2002 Feb; 62(3):941-6. PubMed ID: 11830555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.
    Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A
    FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
    Jirásek T; Hozák P; Mandys V
    Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.
    Indinnimeo M; Cicchini C; Memeo L; Stazi A; Provenza C; Ricci F; Mingazzini PL
    Anticancer Res; 2002; 22(1A):395-8. PubMed ID: 12017321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
    Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
    Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A expression in human colonic adenocarcinoma.
    Romeo R; Pellitteri R; Mazzone V; Marcello MF
    Ital J Anat Embryol; 2002; 107(3):177-83. PubMed ID: 12437144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chromogranin A mRNA in small cell carcinoma of the lung.
    Hamid Q; Corrin B; Sheppard MN; Huttner WB; Polak JM
    J Pathol; 1991 Apr; 163(4):293-7. PubMed ID: 1851827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chromogranin expression on inositol 1,4,5-trisphosphate-induced intracellular Ca2+ mobilization.
    Huh YH; Jeon SH; Yoo JA; Park SY; Yoo SH
    Biochemistry; 2005 Apr; 44(16):6122-32. PubMed ID: 15835900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
    Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
    Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of elevated serum chromogranin A levels.
    Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
    Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polarized secretion of the regulated secretory protein chromogranin A.
    Kühn U; Cohn DV; Gorr SU
    Biochem Biophys Res Commun; 2000 Apr; 270(2):631-6. PubMed ID: 10753675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy.
    Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M
    Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells.
    Hosaka M; Watanabe T; Sakai Y; Uchiyama Y; Takeuchi T
    Mol Biol Cell; 2002 Oct; 13(10):3388-99. PubMed ID: 12388744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
    Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
    Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
    Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.
    Abou-Saif A; Gibril F; Ojeaburu JV; Bashir S; Entsuah LK; Asgharian B; Jensen RT
    Cancer; 2003 Jul; 98(2):249-61. PubMed ID: 12872342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretagogin is a new neuroendocrine marker in the human prostate.
    Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
    Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.
    Kokubo H; Yamada Y; Nishio Y; Fukatsu H; Honda N; Nakagawa A; Saga S; Tsuzuki T; Hara K
    Urology; 2005 Jul; 66(1):135-40. PubMed ID: 15992907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.